Showing results (91-100 of 200) with videos related to

Sort By:
Pageof 20
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 3, 2014
Direct-to-patient disclosure of results of mismatch repair screening for Lynch syndrome via electronic personal health record: a feasibility studyMichael J Hall, Meagan M Herda, Elizabeth A Handorf, et al.
Journal of Genetic Counseling|May 6, 2014
Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testingJennifer M Matro, Karen J Ruth, Yu-Ning Wong, et al.
Communications Medicine|September 30, 2024
Poor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testingSuzanne Schrock-Kelley, Vivienne Souter, Michael J Hall, et al.
Pigment Cell & Melanoma Research|March 24, 2022
Reconstructed human pigmented skin/epidermis models achieve epidermal pigmentation through melanocore transferMichael J Hall, Sara Lopes-Ventura, Matilde V Neto, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 29, 2021
Germline Pathogenic Variants in the Ataxia Telangiectasia Mutated (ATM) Gene are Associated with High and Moderate Risks for Multiple CancersMichael J Hall, Ryan Bernhisel, Elisha Hughes, et al.
Medizinische Klinik, Intensivmedizin Und Notfallmedizin|June 25, 2024
[Overdosing of direct oral anticoagulants]Marie Anne-Catherine Neumann, Noëlle Sieg, Jorge Garcia Borrega, et al.
BMC Cancer|April 2, 2024
Oncologists' perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patientsMichael J Hall, Paul A D'Avanzo, Yana Chertock, et al.
Investigative Ophthalmology & Visual Science|August 7, 2023
Impaired Lysosome Reformation in Chloroquine-Treated Retinal Pigment Epithelial CellsM Helena Cardoso, Michael J Hall, Thomas Burgoyne, et al.
Cancer Treatment Reviews|January 20, 2022
Therapeutic implications of germline vulnerabilities in DNA repair for precision oncologyShreya M Shah, Elena V Demidova, Randy W Lesh, et al.
Investigational New Drugs|August 31, 2010
Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II ConsortiumHedy Lee Kindler, Kristen Wroblewski, James A Wallace, et al.
Pageof 20